ArticleClinical and experimental medicine2009

Promoter methylation of protease-activated receptor (PAR2) is associated with severe clinical phenotypes of ulcerative colitis (UC).

Tomomitsu Tahara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.